1. Home
  2. ABVX vs DINO Comparison

ABVX vs DINO Comparison

Compare ABVX & DINO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$91.50

Market Cap

11.9B

Sector

N/A

ML Signal

HOLD

Logo HF Sinclair Corporation

DINO

HF Sinclair Corporation

SELL

Current Price

$114.91

Market Cap

12.9B

Sector

Energy

ML Signal

SELL

Company Overview

Basic Information
Metric
ABVX
DINO
Founded
2013
1947
Country
France
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Sector
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
12.9B
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
ABVX
DINO
Price
$91.50
$114.91
Analyst Decision
Strong Buy
Hold
Analyst Count
12
16
Target Price
★ $164.00
$102.33
AVG Volume (30 Days)
1.3M
★ 2.6M
Earning Date
09-21-2026
10-28-2026
Dividend Yield
N/A
★ 1.85%
EPS Growth
N/A
★ 238.46
EPS
N/A
★ 8.48
Revenue
N/A
N/A
Revenue This Year
N/A
$29.84
Revenue Next Year
$1,854.09
N/A
P/E Ratio
★ N/A
$13.29
Revenue Growth
N/A
N/A
52 Week Low
$69.81
$45.71
52 Week High
$148.83
$118.39

Technical Indicators

Market Signals
Indicator
ABVX
DINO
Relative Strength Index (RSI) 32.87 67.30
Support Level $74.79 $103.00
Resistance Level $130.96 $118.39
Average True Range (ATR) 4.32 5.21
MACD -0.48 -0.37
Stochastic Oscillator 9.91 77.23

Price Performance

Historical Comparison
ABVX
DINO

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 350 distributors and 1,700 wholesale branded sites across 30 states. It also owns and operates 4,500 miles of petroleum product pipelines and terminals principally in the southwestern United States.

Share on Social Networks: